Johnson Financial Group Inc (Wisconsin)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-907
Closed -$25.6K 620
2022
Q4
$25.6K Buy
907
+657
+263% +$20.9K ﹤0.01% 409
2022
Q3
$8K Sell
250
-1,235
-83% -$45.3K ﹤0.01% 506
2022
Q2
$47K Hold
1,485
﹤0.01% 395
2022
Q1
$68K Hold
1,485
﹤0.01% 395
2021
Q4
$91K Hold
1,485
0.01% 373
2021
Q3
$111K Hold
1,485
0.01% 317
2021
Q2
$137K Hold
1,485
0.01% 302
2021
Q1
$132K Buy
+1,485
New +$147K 0.01% 305

Other funds holding ARKG

Johnson Financial Group Inc (Wisconsin)'s ARKG Position: Q1 2023 in Review

Johnson Financial Group Inc (Wisconsin) sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2023, closing a stake of 907 shares — an estimated $25.6K sold.

Johnson Financial Group Inc (Wisconsin) first reported a position in ARKG in Q1 2021 and held it in 8 quarters. The position peaked at $137K in Q2 2021. 295 funds tracked by Wall St. Rank hold ARKG as of Q1 2023.

  • Johnson Financial Group Inc (Wisconsin) reported no remaining ARK Genomic Revolution ETF position as of Q1 2023 after selling out during the quarter.
  • Johnson Financial Group Inc (Wisconsin) sold 907 ARK Genomic Revolution ETF shares in Q1 2023, an estimated $25.6K.
  • Johnson Financial Group Inc (Wisconsin) first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 8 quarters.
  • Johnson Financial Group Inc (Wisconsin)'s ARK Genomic Revolution ETF position peaked at $137K in Q2 2021.
  • 295 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2023.

Based on Johnson Financial Group Inc (Wisconsin)'s 13F filing for Q1 2023, filed 12 May 2023.